As at 2009, and following the efforts of the Spanish government to boost biomedical research, the Hospital La Paz Institute for Health Research (IdiPAZ) was constituted as a joint-venture among the HULP, its own Foundation for research and the neighbouring UAM. The institute has been accredited by the national
Instituto de Salud Carlos III, a quality seal in Spain. As at 2019, it host more than 50 research groups in six strategic areas: • Neurosciences Area • Cardiovascular Area • Infectious Diseases and Immunity Area • Organ System Pathologies Area • Cancer and Human Molecular Genetics Area • Surgery, Transplant and Health Technologies Area Apart from the excellence of its staff and the quality of their core platforms, IdiPAZ strength resides on the synergies with the hospital day-to-day work, the possibility of expedite clinical trials or dig in its vast archives for research data. IdiPAZ's researchers participates in hundreds of research projects funded either by the regional or national agencies, the
European Union or several private philanthropic organizations. The institute itself is part of two EU-funded distributed research Infrastructures (ERICs): EATRIS (devoted to translational research) and ECRIN (to clinical trials). Taken together the IdiPAZ, the UAM's School of Medicine, the Alberto Sols Biomedical Research Institute (affiliated to the
CSIC), the
Instituto de Salud Carlos III main administrative and research campus (ancient
Hospital del Rey: comprising
CNIO and
CNIC, among other institutes) and even the slightly far away Ramón y Cajal Institute for Health Research (linked to SERMAS' Hospital Universitario Ramón y Cajal) you can find in a couple of square kilometres the biggest biomedical and health research hub of Spain. ==Redevelopment==